Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
30,334,612
-
Share change
-
+6,459,734
-
Total reported value
-
$251,773,789
-
Put/Call ratio
-
24%
-
Price per share
-
$8.30
-
Number of holders
-
92
-
Value change
-
+$56,530,073
-
Number of buys
-
47
-
Number of sells
-
38
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q1 2022
As of 31 Mar 2022,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,334,612 shares.
The largest 10 holders included
AMERIPRISE FINANCIAL INC, 683 Capital Management, LLC, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD GROUP INC, VR Adviser, LLC, MORGAN STANLEY, Soleus Capital Management, L.P., Knoll Capital Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.